Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CAS Medical Systems Inc gives Q4, FY 2013 revenue guidance below analysts' estimates-Conference Call


Wednesday, 8 Jan 2014 08:00am EST 

CAS Medical Systems Inc:Expects net sales for the Q4 2013 to be between $5.85 million and $5.95 million, compared with net sales of $5.95 million for Q4 2012.Expects FY 2013, net sales to be between $21.8 million and $21.9 million, compared with net sales of $22.7 million for FY 2012.Q4 2013 revenue of $6.2 mln - Thomson Reuters I/B/E/S.FY 2013 revenue of $22.8 mln - Thomson Reuters I/B/E/S. 

Company Quote

1.92
0.13 +7.26%
19 Dec 2014